The improvement of modified Si-Miao granule on hepatic insulin resistance and glycogen synthesis in type 2 diabetes mellitus involves the inhibition of TNF-α/JNK1/IRS-2 pathway: network pharmacology, molecular docking, and experimental validation

Abstract Background Modified Si-Miao granule (mSMG), a traditional Chinese medicine, is beneficial for T2DM and insulin resistance (IR), but the underlying mechanism remains unknown. Methods Using network pharmacology, we screened the compounds of mSMG and identified its targets and pathway on hepat...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Zebiao Cao, Xianzhe Wang, Zhili Zeng, Zhaojun Yang, Yuping Lin, Lu Sun, Qiyun Lu, Guanjie Fan
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2024-09-01
Sarja:	Chinese Medicine
Aiheet:	Network pharmacology Molecular docking Modified Si-Miao granule Berberine Type 2 diabetes mellitus Insulin resistance
Linkit:	https://doi.org/10.1186/s13020-024-00997-9
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!